Home › Funds › Soleus Capital Management, L.P. › TNGX
Soleus Capital Management, L.P. position in TNGX
TANGO THERAPEUTICS INC · Health Care
Soleus Capital Management, L.P. reported holding 709,000 shares of TNGX (TANGO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$22.2M, representing 0.76% of its reported portfolio and ranking #36 among its reported holdings. Soleus Capital Management, L.P. has disclosed TNGX holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s TNGX position evolved
Soleus Capital Management, L.P. first disclosed a stake in TNGX in Q3 2023 at 1,929,019 shares (US$21.7M). The position peaked in Q2 2026 at 709,000 shares, worth US$22.2M. Across 10 filings, Soleus Capital Management, L.P. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 709,000 shares valued at US$22.2M — an increase of 259,000 shares quarter over quarter.. Notable position changes include a 67% trim in Q3 2024 (shares fell 60% over the following quarter), a 97% trim in Q4 2025 (shares rose 136% over the following quarter), a 4400% increase in Q1 2026 (shares rose 49% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.93M | $21.72M | New |
| Q4 2023 | 847.14K | $8.39M | Reduce |
| Q1 2024 | 1.35M | $10.72M | Add |
| Q2 2024 | 1.05M | $9.01M | Reduce |
| Q3 2024 | 343.15K | $2.64M | Reduce |
| Q2 2025 | 730.00K | $3.74M | New |
| Q3 2025 | 300.00K | $2.52M | Reduce |
| Q4 2025 | 10.00K | $88.60K | Reduce |
| Q1 2026 | 450.00K | $9.41M | Add |
| Q2 2026 | 709.00K | $22.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TNGX and 13F data
TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 84 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- RTW INVESTMENTS, LP 13.90M sh · $434.53M · Q2 2026
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 12.28M sh · $383.78M · Q2 2026
- Boxer Capital Management, LLC 10.88M sh · $339.99M · Q2 2026
- TCG Crossover Management, LLC 9.08M sh · $283.88M · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $198.74M · Q2 2026
- Siren, L.L.C. 6.18M sh · $193.17M · Q2 2026
- Deep Track Capital, LP 4.20M sh · $131.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M sh · $131.00M · Q2 2026
- Woodline Partners LP 4.00M sh · $125.06M · Q2 2026
- TRV GP IV, LLC 6.37M sh · $120.18M · Q2 2026
- PERCEPTIVE ADVISORS LLC 3.38M sh · $105.57M · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held TNGX?
Soleus Capital Management, L.P. has disclosed TNGX holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is Soleus Capital Management, L.P.'s current position in TNGX?
As of Q2 2026, Soleus Capital Management, L.P. holds 709.00K shares of TNGX (TANGO THERAPEUTICS INC), valued at $22.16M, representing 0.76% of its reported portfolio and ranking #36.
Has Soleus Capital Management, L.P. been buying or selling TNGX?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. increased its position in TNGX. The position peaked in Q2 2026 at 709.00K shares.
Which other funds hold TNGX?
Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 84 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.